Brief: Asset Value Investors - Calling Rohto Pharmaceutical To Focus On Its Core Businesses Rather Than Allocating Resources To Regenerative Medicine Business

Rohto Pharmaceutical

08/04/2025 10:54

April 8 (Reuters) - Rohto Pharmaceutical Co Ltd 4527.T:

ASSET VALUE INVESTORS:  CALLING ROHTO PHARMACEUTICAL TO  FOCUS ON ITS CORE BUSINESSES RATHER THAN ALLOCATING RESOURCES TO REGENERATIVE MEDICINE BUSINESS

ASSET VALUE INVESTORS: ALSO CALLING FOR ROHTO TO ENGAGE WITH SHAREHOLDERS MORE CONSTRUCTIVELY

Source text: [ID:]

Further company coverage: 4527.T

 (Reporting by Tokyo Newsroom)

 ((+81345201189;))